Pharma Inc agrees to cap margins on non-price control drugs at 30%
Wednesday, November 27, 2019, 8:48 PM
The domestic drug-industry and trade have agreed to the government's proposal to cap trade margins for all medicines outside price-control at 30%, a move that will reduce the prices of nearly 80% of formulations. A consensus to this effect was reached at a meeting held on Friday between the drug pricing regulator, pharma lobby groups and industry associations, said people present at the meeting.
At Rs 58.8 cr, Murali of Divi's Lab highest paid Indian pharma executive
Sunday, August 11, 2019, 7:10 PM
Chairman and Managing Director of city-based pharma company C Murali K Divi is the highest paid executive of the Indian pharma industry with Rs 58.8 crore remuneration which includes salary and commission in 2018-19. According to Divis latest annual report, Murali Divi, the promoter-executive,was given a hike of 46.3 per cent in his remuneration over the previous fiscal.